Sage Therapeutics Inc Cash Flow Reinvestment Rate
Sage Therapeutics Inc cash flow reinvestment rate. Sage Therapeutics Inc (SAGE) has a Cash Flow Reinvestment Rate of 0.05x as of December 2020, reinvesting $45.52 Million (capex $1.00K plus investments $45.52 Million) from operating cash flow of $1.01 Billion. Explore SAGE cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Sage Therapeutics Inc (2020–2020)
Cash flow reinvestment rate of Sage Therapeutics Inc from 2020 to 2020. Historical reinvestment intensity for Sage Therapeutics Inc across 1 annual periods. Explore SAGE capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Sage Therapeutics Inc Cash Flow Reinvestment Rate by Year (2020–2020)
Sage Therapeutics Inc cash flow reinvestment rate by year from 2020 to 2020. Year-by-year capital reinvestment analysis for Sage Therapeutics Inc. For the full cash flow conversion analysis, see cash flow conversion of Sage Therapeutics Inc.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2020 | 0.67x | $443.37 Million | $664.28 Million | $345.00K | — |